Donor HSCs with a preexisting ASXL1-mutation led to the development of FLT3-ITD positive AML in the donor and FLT3-ITD negative AML in the recipient after unrelated transplant.
about
Donor HSCs with a preexisting ASXL1-mutation led to the development of FLT3-ITD positive AML in the donor and FLT3-ITD negative AML in the recipient after unrelated transplant.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Donor HSCs with a preexisting ...... nt after unrelated transplant.
@en
Donor HSCs with a preexisting ...... nt after unrelated transplant.
@nl
type
label
Donor HSCs with a preexisting ...... nt after unrelated transplant.
@en
Donor HSCs with a preexisting ...... nt after unrelated transplant.
@nl
prefLabel
Donor HSCs with a preexisting ...... nt after unrelated transplant.
@en
Donor HSCs with a preexisting ...... nt after unrelated transplant.
@nl
P2093
P2860
P1476
Donor HSCs with a preexisting ...... nt after unrelated transplant.
@en
P2093
Hafiz Abdul Waqas Ahmed
Hongxing Liu
Meiying Wen
Mingyi Chen
Mingyue Shi
William J Murphy
P2860
P2888
P356
10.1038/S41409-017-0046-8
P407
P577
2018-01-12T00:00:00Z
P6179
1100248962